Donépézil (Aricept®)

  • Trivalle C
  • 2


    Mendeley users who have this article in their library.
  • 1


    Citations of this article.


Donepezil is one of the reversible acetylcholinesterase inhibitors which has been licensed in France since 1997 for use in patients with mild to moderate Alzheimer's disease. There is an abundant body of recently published on this molecule. This article is a review of the main papers relevant to donepezil. © 2008 Elsevier Masson SAS. All rights reserved.

Author-supplied keywords

  • Acetylcholinesterase inhibitor
  • Alzheimer's disease
  • Donepezil
  • Elderly

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free